180 Life Sciences Corp. (NASDAQ:ATNF) shares, rose in value on Thursday, Apr 08, with the stock price up by 14.02% to the previous day’s close as strong demand from buyers drove the stock to $9.04.
Actively observing the price movement in the recent trading, the stock is buoying the session at $7.93, falling within a range of $8.01 – and $10.30. The value of beta (5-year monthly) is -0.72 whereas the PE ratio is 0 over 12-month period. Referring to stock’s 52-week performance, its high was $11.5, and the low was $1.9. On the whole, ATNF has fluctuated by 86.59% over the past month.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that ATNF’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of Hold while long term indicators on average have been pointing out that it is a 50% Buy.
A comparison of 180 Life Sciences Corp. (ATNF) with its peers suggests the former has fared considerably weaker in the market. ATNF showed an intraday change of +14.02% in today’s session so far, and over the past year, it dropped by -23.9%. In comparison, Amgen Inc (AMGN) has moved lower at -0.3% today and is up +17.27% over the past 12 months. On the other hand, the price of Bristol-Myers Squibb Company (BMY) has risen 0.23% today. The stock, however, is off 7.24% from where it was a year ago. Additionally, there is a gain of 1402% for Gilead Sciences Inc (GILD) in recent trading while the stock has seen an overall depriciation of -23.9% over the past year. The PE ratio stands at 0 for 180 Life Sciences Corp., compared to 20.15 for Amgen Inc, and 0 for Bristol-Myers Squibb Company. Other than that, the overall performance of the S&P 500 during the today’s session so far shows that it gained 0.29%. Meanwhile, the Dow Jones Industrial weakened by -0.03%.
Data on historical trading for 180 Life Sciences Corp. (NASDAQ:ATNF) indicates that the trading volumes over the past 10 days have averaged 1.35 Million and over the past 3 months, they’ve averaged 2.24 Million. According to company’s latest data on outstanding shares, there are 24.07 Million shares outstanding.
Nearly 42.78% of 180 Life Sciences Corp.’s shares belong to company insiders and institutional investors own 7.01% of the company’s shares, according to Thomson Reuters’ data. The data on short interest also indicates that stock shorts accounted for 2.27 Million shares as on March 14, 2021, resulting in a short ratio of 1.76. According to the data, the short interest in 180 Life Sciences Corp. (ATNF) stood at 9.44% of shares outstanding as of March 14, 2021; the number of short shares registered in February reached 461.17 Million. The stock has risen by +190.48% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ATNF stock heading into the next quarter.